Case 2: Due to a national shortage of 1.0 mg semaglutide, a female whose weight was previously stable on phentermine 15mg/topiramate 25mg twice daily plus GLP-1 agonist therapy (i.e., semaglutide) was switched to 5mg tirzepatide in-between clinic visits
Brain tissue homogenates and serum samples were collected to quantify intestinal permeability markers (zonulin and occluding), oxidative-stress markers (GSH, MDA, CAT), and GABA-receptor gene expression using ELISA and biochemical assays
In many cases, manufacturers pursue biosimilar pathways instead of standard generic approval processes
Carbohydrate timing matters
We do not provide therapeutic claims, dosing guidance, administration protocols, or any content relating to human or veterinary use